The Venture Codex Logo

The Venture Codex

Overview

Biotech company developing therapies targeting metabolic conditions.

Total Raised

$114 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Health Care
Medical
Pharmaceutical

Investment History

  1. Series C

    Oct 2022

    $69M

  2. Series B

    Sep 2020

    $38M

  3. Series A

    Jul 2018

    $7M

Team

François Ravenelle

President and CEO

Jamie Stiff

Director

Michael D. Harvey

Chief Development Officer

Glenn S. Vraniak

Chief Financial Officer